Neuroone Medical Technologies is trading 11.16% up at $2.09, outperforming a weaker broad market as healthcare gains 1.59%.
- No new company-specific announcement dated August 18, 2026 was identified.
- The latest catalyst remains the August 13 earnings update: orders rose 43% year over year and backlog reached a record $1.7 million.
- Earnings missed estimates, and fiscal revenue guidance was reduced.